首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Evaluation of dalbavancin as chiral selector for HPLC and comparison with teicoplanin‐based chiral stationary phases
Authors:Xiaotong Zhang  Ye Bao  Ke Huang  Kimber L Barnett‐Rundlett  Daniel W Armstrong
Institution:1. Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, Texas;2. Pfizer, Inc., Groton, Connecticut
Abstract:Dalbavancin is a new compound of the macrocyclic glycopeptide family. It was covalently linked to 5 μm silica particles using two different binding chemistries. Approximately 250 racemates including (a) heterocyclic compounds, (b) chiral acids, (c) chiral amines, (d) chiral alcohols, (e) chiral sulfoxides and sulfilimines, (f) amino acids and amino acid derivatives, and (g) other chiral compounds were tested on the two new chiral stationary phases (CSPs) using three different mobile phases. As dalbavancin is structurally related to teicoplanin, the same set of chiral compounds was screened on two commercially available teicoplanin CSPs for comparison. The dalbavancin CSPs were able to separate some enantiomers that were not separated by the teicoplanin CSPs and also showed improved separations for many racemates. However, there were other compounds only separated or better separated on teicoplanin CSPs. Therefore, the dalbavancin CSPs are complementary to the teicoplanin CSPs. Chirality, 2010. © 2009 Wiley‐Liss, Inc.
Keywords:dalbavancin  teicoplanin  chiral stationary phases  HPLC  macrocyclic glycopeptides  racemates  enantiomeric separation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号